A PARP inhibitor, rucaparib, improves cardiac dysfunction in <i>ADP-ribose-acceptor hydrolase 3</i> ( <i>Arh3</i> ) deficiency.

Yamashita, Sachiko; Bu, Xiangning; Ishiwata-Endo, Hiroko; Kato, Jiro; Springer, Danielle; Noguchi, Audrey; Peiravi, Morteza; Liu, Chengyu; Zhang, Fan; Yu, Zu-Xi; Clevenger, Randy; Keeran, Karen; San, Hong; Lizak, Martin J; Moss, Joel

A PARP inhibitor, rucaparib, improves cardiac dysfunction in ADP-ribose-acceptor hydrolase 3 ( Arh3 ) deficiency.

Yamashita, Sachiko; Bu, Xiangning; Ishiwata-Endo, Hiroko; Kato, Jiro; Springer, Danielle; Noguchi, Audrey; Peiravi, Morteza; Liu, Chengyu; Zhang, Fan; Yu, Zu-Xi; Clevenger, Randy; Keeran, Karen; San, Hong; Lizak, Martin J; Moss, Joel.

bioRxiv ; 2023 Feb 07.

Article in En | MEDLINE | ID: mdl-36945462

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028743
https://dx.doi.org/10.1101/2023.02.07.527369

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BioRxiv Year: 2023 Document type: Article

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028743
https://dx.doi.org/10.1101/2023.02.07.527369

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: BioRxiv Year: 2023 Document type: Article